Your browser doesn't support javascript.
loading
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
Saito, Sho; Kutsuna, Satoshi; Akifumi, Imamura; Hase, Ryota; Oda, Rentaro; Terada, Junko; Shimizu, Yosuke; Uemura, Yukari; Takamatsu, Yuki; Yasuhara, Akemi; Shiratori, Katsuyuki; Satake, Masahiro; Sakamoto, Naoya; Miyazaki, Yasunari; Shimizu, Hidefumi; Togano, Tomiteru; Matsunaga, Akihiro; Okuma, Kazu; Hamaguchi, Isao; Fujisawa, Kyoko; Nagashima, Maki; Ashida, Shinobu; Terada, Mari; Kimura, Akiko; Morioka, Shinichiro; Matsubayashi, Keiji; Tsuno, Nelson Hirokazu; Kojima, Makiko; Kuramitsu, Madoka; Tezuka, Kenta; Ikebe, Emi; Ishizaka, Yukihito; Kenji, Maeda; Hangaishi, Akira; Mikami, Ayako; Sugiura, Wataru; Ohmagari, Norio; Mitsuya, Hiroaki.
Affiliation
  • Saito S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan. Electronic address: ssaito@hosp.ncgm.go.jp.
  • Kutsuna S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Department of Infection Control, Graduate School of Medicine Faculty of Medicine, Osaka University, Osaka, Japan.
  • Akifumi I; Department of Infectious Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
  • Hase R; Department of Infectious Diseases, Japanese Red Cross Narita Hospital, Chiba, Japan.
  • Oda R; Division of Infectious Diseases, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan.
  • Terada J; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Shimizu Y; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Uemura Y; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Takamatsu Y; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Yasuhara A; Joint Center for Researchers, Associates and Clinicians Data Center, Department of Data Science, Center for Clinical Sciences, National Center for Global Health and Medicine, Tokyo, Japan.
  • Shiratori K; Clinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
  • Satake M; Japanese Red Cross Central Blood Institute, Tokyo, Japan.
  • Sakamoto N; Department of Infectious Diseases, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
  • Miyazaki Y; Department of Respiratory Medicine, Tokyo Medical and Dental University, Tokyo, Japan.
  • Shimizu H; Department of Respiratory Medicine, JCHO Tokyo Shinjuku Medical Center, Tokyo, Japan.
  • Togano T; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Matsunaga A; Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
  • Okuma K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan; Department of Microbiology, Faculty of Medicine, Kansai Medical University, Osaka, Japan.
  • Hamaguchi I; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Fujisawa K; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Nagashima M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ashida S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Terada M; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kimura A; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Morioka S; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Matsubayashi K; Japanese Red Cross Central Blood Institute, Tokyo, Japan.
  • Tsuno NH; Japanese Red Cross Kanto-Koshin-etsu Block Blood Center, Tokyo, Japan.
  • Kojima M; Japanese Red Cross Central Blood Institute, Tokyo, Japan; Japanese Red Cross Kanto-Koshin-etsu Block Blood Center, Tokyo, Japan.
  • Kuramitsu M; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Tezuka K; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ikebe E; Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Tokyo, Japan.
  • Ishizaka Y; Department of Intractable Diseases, National Center for Global Health and Medicine, Tokyo, Japan.
  • Kenji M; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
  • Hangaishi A; Department of Hematology, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mikami A; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan; Center for Clinical Research, National Center for Child Health and Development, Tokyo, Japan.
  • Sugiura W; Center for Clinical Science, National Center for Global Health and Medicine, Tokyo, Japan.
  • Ohmagari N; Disease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
  • Mitsuya H; Department of Refractory Viral Infections, National Center for Global Health and Medicine Research Institute, Tokyo, Japan.
J Infect Chemother ; 29(9): 869-874, 2023 Sep.
Article in En | MEDLINE | ID: mdl-37178973
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Humans Country/Region as subject: Asia Language: En Journal: J Infect Chemother Year: 2023 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Health context: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: COVID-19 Type of study: Clinical_trials Limits: Humans Country/Region as subject: Asia Language: En Journal: J Infect Chemother Year: 2023 Document type: Article